PHAItMA
Citi Pharma Limited
The General Manager
Pakistan Stock Exchange Limited Stock Exchange Building
Stock Exchange Road Karachi
October 27, 2025
SUBJECT: Certified True Copy of the Resolutions Passed in the Annual General Meeting of the Citi Pharma Limited.Dear Sir
Pursuant to the requirement ofListing Regulation No. 5.6.9(b) of the Rule Book ofPakistan Stock Exchange Limited, we are pleased to submit herewith certified true copy of theresolutions adopted by the Shareholders of the Citi Pharma Limited in the Annual general Meeting held on Monday, October 27, 2025 at 12:30 Pm at 588 Block Q, Phase 2 Johar Town, Lahore, for your reference and record.
Yours faithfully,
Compan étarysae - q, johar Town, Lahore - Pakistan 3KM. Head Balloki Road, Phool Nagar, District Kasur - Pakistan Head Office :+92. 42. 35316587 - so I Factow: +92. 49. 451O1B9, +92. A9. 4513392 https://www.citipharma.com.pk
PHARMA
Citi Pharma Limited
Certified True Copies of the Resolutions unanimously passed and adopted by the shareholders of Citi Pharma Limited at the Annual General Meeting held on October 27, 2025 Ordinary Business:
To confirm the minutes of last Extra Ordinary General Meeting (EOGM) held on June 26, 2025.
"RESOLVED that the Minutes of the Extra Ordinary General Meeting (EOGM) held on June 26, 2025, be and hereby are confirmed and adopted."
To receive, consider and adopt the Audited Financial Statements of the Company for the year ended June 30, 2025 together with Directors' and Auditors' Report thereon.
'RESOLVED that the Audited Financial Statements of the Company for the year ended June 30, 2025, audited by Mls. Aslam Malik & Co., Chartered .Accountants together with the report to Shareholders and Auditors' Report thereon, be and are hereby approved.
To lay information before the members of the Company after appointment of M/s. Aslam Malik & Co., Chartered Accountants, as external auditors of the Company for the year ending June 30, 2026.
IT IS HEREBY RESOLVED that that the appointment of Mls. Aslam Xlalik & Co., Chartered Accountants, as the external auditor for the Company for the fiscal year ending June 30, 2026, at a remuneration set by the Board of Directors (Recommcnded by AC), is hereby confirmed and approved.
To approve payment of final cash dividend of Rs. 3.5 per share i.e., 35% for the year ended June 30, 2025, as recommended by the Board of Directors.
"RESOLVED that the recommendation of the Board of Management for the pay ment of a final cash dividend of Rs. 3.5 per share, representing 35% for the financial year ended June 30, 2025, is hereby approved.
4 o elect seven (07) Directors of the Company as fixed by the Board of Directors, for a term of three years commencing from October 27, 2025 in accordance with the provisions of the Companies Act, 2017 in place of retiring Directors namely:
588 - Q, Johar Town, Lahore - Pakistan 3KM. Head Balloki Road, Phool Nagar, District Kasur - Pakistan
"@ Head Office : +92. 62. 35316587 - 90 | Factory: +92. /+9. 4510189, +92. 49. 4513392 https://www.citipharma.com.pk
PHARMA
Citi Pharma Limited
Mr. Nadeem Amjad
Mr. Rizwan Ahmad
Mr. Zameer UI Hassan Shah
Mr. Muhammad Naeem
S. Mr. Abdul Jaleel Sheikh
Mrs. Saima Shafi Rana
Mrs. Saira Aslam
Statement under section 166(3) pertaining to Election of Directors being circulated to the members along with notice of the meeting.
"RESOLVED that the following persons are hereby declared elected unopposed as Directors of the Company for a term ofthree years commencing from October 27, 2025:
Mr. Nadeem Amjad
Mr. Rizwan Ahmad
Mr. Zameer UI Hassan Shah
Mr. Muhammad Naeem
S. Mr. Abdul Jaleel Sheikh
Mrs. Saima Shaft Rana
Mrs. Saira Aslam
- To transact any other business with the permission of the Chair.
Since no further matters were proposed for discussion, the Chairman declared that there being no other business to transact, the meeting stood concluded with a vote of thanks to the Chair.
Certified True Copy issued on October 27, 2025 Compan cretarySBB - Q,]oharTown, Lahore - Pakistan 3XM. Head Balloki Road, Phool Nagar, District Kasur - Pakistan
Head Office: +S2. 42. 35316587 - 90 | Factory: +92. 49. 4510189,+92. 49. 4513392 https://www.citipharma.com.pk
